Telix Pharmaceuticals Limited (NASDAQ:TLX) Q4 2025 Earnings Call Transcript February 20, 2026
Operator: Good day, and thank you for standing by. Welcome to the Telix Full Year 2025 Results and Investor Webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Kyahn Williamson, SVP of Investor Relations and Corporate Communications. Please go ahead.
Kyahn Williamson: Thank you, and thank...
